Mumbai, Jan. 3 -- Torrent Pharmaceuticals said India Ratings and Research has reaffirmed the credit rating of the company's existing banking facilities, issuer rating and non-convertible debentures at IND AA+ with a stable outlook.

The rating agency has also assigned a short-term rating of IND A1+ to Torrent Pharma's proposed commercial paper programme, indicating a strong degree of safety with respect to timely servicing of financial obligations.

The company's securities transfer and stakeholders relationship committee will meet on 5 January 2026 to consider the issuance of secured non-convertible debentures through a private placement, within the borrowing limits already approved by the board in July 2025.

Torrent Pharma is the flags...